These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 21303639)

  • 1. Evaluation of dexterity in insulin-treated patients with type 1 and type 2 diabetes mellitus.
    Pfützner J; Hellhammer J; Musholt P; Pfützner AH; Böhnke J; Torsten H; Amann-Zalan I; Ganz M; Forst T; Pfützner A
    J Diabetes Sci Technol; 2011 Jan; 5(1):158-65. PubMed ID: 21303639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Self-assessment and objective determination of dexterity in patients with type 1 or type 2 diabetes mellitus.
    Pfützner A; Musholt PB; Schipper C; Niemeyer M; Qvist M; Schorsch A; Forst T
    Curr Med Res Opin; 2012 Jan; 28(1):15-21. PubMed ID: 22087736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of patient preference for two insulin injection pen devices in relation to patient dexterity skills.
    Pfützner A; Schipper C; Niemeyer M; Qvist M; Löffler A; Forst T; Musholt PB
    J Diabetes Sci Technol; 2012 Jul; 6(4):910-6. PubMed ID: 22920818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glycemic variability in inadequately controlled type 1 diabetes and type 2 diabetes on intensive insulin therapy: a cross-sectional, observational study.
    Greven WL; Beulens JW; Biesma DH; Faiz S; de Valk HW
    Diabetes Technol Ther; 2010 Sep; 12(9):695-9. PubMed ID: 20687867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient device assessment evaluation of two insulin injection devices in a mixed cohort of insulin-treated patients with type 1 or type 2 diabetes mellitus.
    Schipper C; Musholt P; Niemeyer M; Qvist M; Löffler A; Forst T; Pfützner A
    Curr Med Res Opin; 2012 Aug; 28(8):1297-303. PubMed ID: 22746353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between metabolic control and self-monitoring of blood glucose in insulin-treated patients with diabetes mellitus.
    Soto González A; Quintela Fernández N; Pumar López A; Darias Garzón R; Rivas Fernández M; Barberá Comes G
    Endocrinol Nutr; 2015 May; 62(5):233-9. PubMed ID: 25814324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS AND AMERICAN COLLEGE OF ENDOCRINOLOGY 2018 POSITION STATEMENT ON INTEGRATION OF INSULIN PUMPS AND CONTINUOUS GLUCOSE MONITORING IN PATIENTS WITH DIABETES MELLITUS.
    Grunberger G; Handelsman Y; Bloomgarden ZT; Fonseca VA; Garber AJ; Haas RA; Roberts VL; Umpierrez GE
    Endocr Pract; 2018 Mar; 24(3):302-308. PubMed ID: 29547046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors associated with withdrawal from insulin pump therapy: A large-population-based study.
    Merzon E; Grossman J; Vinker S; Merhasin I; Levit S; Golan-Cohen A
    Diabetes Metab Res Rev; 2020 May; 36(4):e3288. PubMed ID: 31922314
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Real-world evidence for computerized insulin dose-adjustment algorithms in the effective use of continuous glucose monitoring by primary care clinicians.
    Davidson MB; Davidson SJ
    Diabetes Obes Metab; 2024 Aug; 26(8):3475-3477. PubMed ID: 38860407
    [No Abstract]   [Full Text] [Related]  

  • 10. Relation Between Hypoglycemia and Glycemic Variability in Type 2 Diabetes Patients with Insulin Therapy: A Study Based on Continuous Glucose Monitoring.
    Uemura F; Okada Y; Torimoto K; Tanaka Y
    Diabetes Technol Ther; 2018 Feb; 20(2):140-146. PubMed ID: 29293363
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do perceptions of insulin pump usability impact attitudes toward insulin pump therapy? A pilot study of individuals with type 1 and insulin-treated type 2 diabetes.
    Chamberlain JJ; Gilgen E
    J Diabetes Sci Technol; 2015 Jan; 9(1):105-10. PubMed ID: 25269659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of Continuous Glucose Monitoring in Insulin-Requiring Patients with Diabetes.
    Welsh JB
    Diabetes Technol Ther; 2018 Jun; 20(S2):S242-S249. PubMed ID: 29916736
    [No Abstract]   [Full Text] [Related]  

  • 13. Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study.
    Zaccardi F; Rocca B; Rizzi A; Ciminello A; Teofili L; Ghirlanda G; De Stefano V; Pitocco D
    Nutr Metab Cardiovasc Dis; 2017 Oct; 27(10):902-909. PubMed ID: 28838851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Insulin Pump Therapy and Multiple Daily Injections Insulin Regimen in Patients with Type 1 Diabetes During Ramadan Fasting.
    Alamoudi R; Alsubaiee M; Alqarni A; Saleh Y; Aljaser S; Salam A; Eledrisi M
    Diabetes Technol Ther; 2017 Jun; 19(6):349-354. PubMed ID: 28296467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous Glucose Monitoring: A Review of Recent Studies Demonstrating Improved Glycemic Outcomes.
    Rodbard D
    Diabetes Technol Ther; 2017 Jun; 19(S3):S25-S37. PubMed ID: 28585879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
    Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
    J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reducing Hypoglycemia in the Real World: A Retrospective Analysis of Predictive Low-Glucose Suspend Technology in an Ambulatory Insulin-Dependent Cohort.
    Müller L; Habif S; Leas S; Aronoff-Spencer E
    Diabetes Technol Ther; 2019 Sep; 21(9):478-484. PubMed ID: 31329468
    [No Abstract]   [Full Text] [Related]  

  • 19. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the Pharmacokinetic and Pharmacodynamic Relationship of Ipragliflozin Between Patients With Type 1 and Type 2 Diabetes Mellitus.
    Toyoshima J; Saito M; Kaibara A; Isaka H; Sakatani T
    Clin Ther; 2020 Sep; 42(9):1787-1798.e3. PubMed ID: 32839028
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.